n (%) | |
Masaoka | |
Stage I | 23 (35.4%) |
Stage II | 18 (27.7%) |
Stage III | 11 (16.9%) |
Stage IV | 13 (20.0%) |
WHO (n = 60) | |
A | 4 (6.7%) |
AB | 9 (15.0%) |
B | 46 (76.7%) |
Mixed | 1 (1.6%) |